This company seems to have been delisted
Reason: Acquired by Sobi
Last recorded trade on: August 25, 2023
Source: https://finance.yahoo.com/news/sobi-completes-acquisition-cti-biopharma-134500966.html
Reason: Acquired by Sobi
Last recorded trade on: August 25, 2023
Source: https://finance.yahoo.com/news/sobi-completes-acquisition-cti-biopharma-134500966.html
CTI BioPharma
CTIC
$12.81
Share price
0.00%
Change (1 day)
35.90%
Change (1 year)
Categories
P/S ratio for CTI BioPharma (CTIC)
P/S ratio on August 25, 2023 (TTM) : 15.8
According to CTI BioPharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -47.3. At the end of 2023 the company had a P/S ratio of 7.31.
P/S ratio history for CTI BioPharma from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 7.31 | -48.3% |
| 2022 | 14.1 | |
| 2021 | N/A | |
| 2020 | N/A | -100% |
| 2019 | 27.4 | 1568.81% |
| 2018 | 1.64 | -64.16% |
| 2017 | 4.58 | 128.47% |
| 2016 | 2.00 | -90.64% |
| 2015 | 21.4 | 208.27% |
| 2014 | 6.94 | -13.36% |
| 2013 | 8.01 | |
| 2012 | N/A | |
| 2011 | N/A | -100% |
| 2010 | 931 | -88.93% |
| 2009 | > 1000 | 1174734.83% |
| 2008 | 0.7160 | -99.91% |
| 2007 | 761 | -75.95% |
| 2006 | > 1000 | 32410.49% |
| 2005 | 9.73 | -42.02% |
| 2004 | 16.8 | 41.05% |
| 2003 | 11.9 | -15.38% |
| 2002 | 14.1 | -89.23% |
| 2001 | 131 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 4.97 | -68.57% | 🇺🇸 USA |
 | 2.48 | -84.33% | 🇺🇸 USA |
 | 2.85 | -81.98% | 🇺🇸 USA |
 | 1.26 | -92.01% | 🇺🇸 USA |
 | 15.9 | 0.63% | 🇺🇸 USA |
 | 1.04 | -93.44% | 🇮🇱 Israel |
 | 4.31 | -72.76% | 🇨🇭 Switzerland |